Alpine Immune Sciences (ALPN) stock Forecast for 2021 – 2025

Alpine Immune Sciences (ALPN) stock Forecast for 2022 – 2026

Last update: 05-17-2022, 6:38

Sector: Healthcare

The share price of Alpine Immune Sciences, Inc. (ALPN) now

What analysts predict:: $20

52-week high/low: $15.14 / $6

50/200 Day Moving Average: $8.55 / $10.03

This figure corresponds to the average price over the previous 50/200 days. For Alpine Immune Sciences stocks, the 50-day moving average is the resistance level today.

For Alpine Immune Sciences stocks, the 200-day moving average is the resistance level today.

Are you interested in Alpine Immune Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alpine Immune Sciences stock price in 2022, 2023, 2024, 2025, 2026. How much will one Alpine Immune Sciences share be worth in 2022 - 2026?

When should I take profit in Alpine Immune Sciences stock? When should I record a loss on Alpine Immune Sciences stock? What are analysts' forecasts for Alpine Immune Sciences stock? What is the future of Alpine Immune Sciences stock?

We forecast Alpine Immune Sciences stock performance using neural networks based on historical data on Alpine Immune Sciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alpine Immune Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alpine Immune Sciences shares. This happens once a day.




Historical and forecast chart of Alpine Immune Sciences stock

The chart below shows the historical price of Alpine Immune Sciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alpine Immune Sciences stock price can be found in the table below.

Long-term forecasts by years.

Alpine Immune Sciences daily forecast for a month

Date Target Pes. Opt. Vol., %
May 19 7.86 7.75 8.00 3.12
May 20 7.84 7.69 7.96 3.49
May 21 7.81 7.70 8.04 4.39
May 22 7.54 7.35 7.72 4.99
May 23 7.56 7.35 7.72 5.12
May 24 7.76 7.69 7.97 3.56
May 25 7.71 7.65 7.80 1.88
May 26 7.69 7.56 7.76 2.67
May 27 7.44 7.26 7.61 4.71
May 28 7.42 7.36 7.52 2.22
May 29 7.34 7.23 7.54 4.24
May 30 7.20 7.04 7.38 4.90
May 31 7.07 6.89 7.15 3.78
Jun 01 7.24 7.10 7.40 4.22
Jun 02 7.20 7.01 7.42 5.77
Jun 03 7.09 6.97 7.23 3.79
Jun 04 7.31 7.25 7.48 3.10
Jun 05 7.35 7.24 7.57 4.51
Jun 06 7.24 7.13 7.46 4.59
Jun 07 7.00 6.95 7.10 2.26
Jun 08 6.93 6.72 6.99 3.95
Jun 09 6.74 6.59 6.91 4.86
Jun 10 6.84 6.78 6.92 1.95
Jun 11 6.92 6.81 7.12 4.60
Jun 12 7.16 6.97 7.25 3.98
Jun 13 7.38 7.18 7.50 4.41
Jun 14 7.14 7.08 7.22 2.07
Jun 15 6.98 6.85 7.15 4.41
Jun 16 7.01 6.91 7.20 4.20
Jun 17 7.08 6.94 7.23 4.15

Alpine Immune Sciences Daily Price Targets


Alpine Immune Sciences Stock Forecast 05-19-2022.

Forecast target price for 05-19-2022: $7.86. Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.024%.

Pessimistic target level: 7.75

Optimistic target level: 8.00


Alpine Immune Sciences Stock Forecast 05-20-2022.

Forecast target price for 05-20-2022: $7.84. Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.370%.

Pessimistic target level: 7.69

Optimistic target level: 7.96


Alpine Immune Sciences Stock Forecast 05-21-2022.

Forecast target price for 05-21-2022: $7.81. Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 4.209%.

Pessimistic target level: 7.70

Optimistic target level: 8.04


Alpine Immune Sciences Stock Forecast 05-22-2022.

Forecast target price for 05-22-2022: $7.54. Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 4.750%.

Pessimistic target level: 7.35

Optimistic target level: 7.72


Alpine Immune Sciences Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $7.56. Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 4.872%.

Pessimistic target level: 7.35

Optimistic target level: 7.72


Alpine Immune Sciences Stock Forecast 05-24-2022.

Forecast target price for 05-24-2022: $7.76. Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.440%.

Pessimistic target level: 7.69

Optimistic target level: 7.97


ALPN (ALPN) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 7.06 6.17 7.97 22.55
Jul. 7.88 7.42 8.48 12.48
Aug. 8.38 7.89 9.23 14.53
Sep. 7.48 6.54 8.12 19.47
Oct. 6.53 6.16 7.29 15.47
Nov. 7.38 6.78 7.95 14.71
Dec. 7.50 6.83 8.28 17.54

Alpine Immune Sciences forecast for this year


Alpine Immune Sciences Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $7.06429. Pessimistic: $6.17. Optimistic: $7.97


Alpine Immune Sciences Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $7.87809. Pessimistic: $7.42. Optimistic: $8.48


Alpine Immune Sciences Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $8.38229. Pessimistic: $7.89. Optimistic: $9.23


Alpine Immune Sciences Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $7.48371. Pessimistic: $6.54. Optimistic: $8.12


Alpine Immune Sciences Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $6.5258. Pessimistic: $6.16. Optimistic: $7.29


Alpine Immune Sciences Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $7.38198. Pessimistic: $6.78. Optimistic: $7.95


Alpine Immune Sciences Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $7.50009. Pessimistic: $6.83. Optimistic: $8.28




Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 7.94 7.42 8.24 9.88
Feb 8.40 8.05 8.93 9.79
Mar 8.89 8.08 9.35 13.68
Apr 8.43 7.61 9.13 16.69
May 7.43 7.03 8.18 14.10
Jun 8.51 7.49 8.96 16.41
Jul 9.20 8.34 10.11 17.47
Aug 10.20 9.54 10.96 12.95
Sep 11.24 10.31 12.50 17.55
Oct 11.40 10.25 12.00 14.59
Nov 12.11 10.80 13.14 17.85
Dec 12.48 11.32 13.02 13.04

Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 11.78 10.43 12.95 19.51
Feb 11.10 9.81 12.31 20.35
Mar 10.32 9.86 10.77 8.44
Apr 9.40 8.69 10.39 16.35
May 10.10 9.73 10.77 9.61
Jun 10.78 9.51 12.04 21.06
Jul 11.30 10.45 12.42 15.87
Aug 10.83 9.55 11.61 17.76
Sep 11.30 10.30 12.31 16.30
Oct 10.38 9.65 11.36 15.06
Nov 10.08 9.40 10.96 14.26
Dec 9.53 8.57 10.09 15.11



Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 10.19 9.66 10.77 10.29
Feb 10.30 9.39 11.47 18.10
Mar 9.79 9.37 10.29 8.98
Apr 9.13 8.65 9.51 9.06
May 9.53 9.11 10.42 12.57
Jun 10.24 9.31 11.19 16.84
Jul 9.54 8.93 10.09 11.50
Aug 9.09 8.45 9.92 14.81
Sep 7.86 7.37 8.76 15.93
Oct 7.03 6.36 7.29 12.65
Nov 7.02 6.26 7.35 14.81
Dec 7.24 6.44 7.58 14.98

Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 7.55 6.84 8.41 18.68
Feb 8.65 8.38 9.62 12.95
Mar 8.21 7.30 9.00 18.83
Apr 7.62 6.97 7.97 12.54
May 7.06 6.34 7.40 14.35
Jun 6.62 6.34 7.06 10.19
Jul 6.73 5.95 7.26 18.10
Aug 6.91 6.53 7.74 15.57
Sep 6.58 6.04 7.26 16.81
Oct 6.98 6.32 7.77 18.68
Nov 5.90 5.67 6.44 12.02
Dec 5.01 4.37 5.57 21.44

Alpine Immune Sciences information and performance

Alpine Immune Sciences, Inc. Is a biopharmaceutical company. The company is focused on the discovery and development of protein immunotherapy for the treatment of cancer, autoimmune and inflammatory diseases. The Company’s scientific platform uses a directed evolutionary process to convert native immune system proteins from the immunoglobulin superfamily (IgSF) into multipurpose therapeutic drugs capable of modulating the human immune system. Its candidate products include ALPN-101, ALPN-202 and ALPN-303. ALPN-101 is a dual inducible T cell costimulant (ICOS) and differentiation cluster 28 (CD28) antagonist for the treatment of autoimmune and inflammatory diseases. His cancer program is ALPN-202, a conditional CD28 co-stimulator and dual checkpoint inhibitor for cancer treatment. ALPN-303 is a dual antagonist of B-cell cytokines for the treatment of B-cell mediated diseases.

Alpine Immune Sciences Address

201 ELLIOTT AVE. WEST, SUITE 230, SEATTLE, WA, US

Market Capitalization: 203 421 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -48 231 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.98

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: -0.197

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.531

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 30316100

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A


Alpine Immune Sciences (ALPN) stock dividend

Alpine Immune Sciences last paid dividends on 01/01/1970. The next scheduled payment will be on 07/25/2017. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.